Today on CCTR: Bexion Pharmaceuticals Introduces Phase II Clinical Trial for DIPG/DMG with BXQ-350
Today on Childhood Cancer Talk Radio on TogiNet.com at 4pm EST, Founder and CEO of Bexion Pharmaceuticals Dr. Ray Takigiku and Medical Affairs Consultant and Leader of the phase II clinical trial for DIPG/DMG at Cincinnati Children’s Hospital, Dr. Richard Curry. Both scientists provide insight into the…
